Capstone Therapeutics Corp (CAPS)

36.01 +0.00  +0.00% OTC Markets Jun 16, 20:00 USD
View Full Chart
Price Chart
View All CAPS News

News

View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Capstone Therapeutics Corp is a biotechnology company, which develops a pipeline of novel therapeutic peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs for the treatment of Homozygous Familial Hypercholesterolemia, other hyperlipidemic indications, and acute coronary syndrome/atherosclerosis regression.
  • URL: http://www.capstonethx.com
  • Investor Relations URL: N/A
  • HQ State/Province: Illinois
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Nov. 09, 2009
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.